Daridorexant Hydrochloride is a dual orexin receptor antagonist used in the treatment of adult insomnia by blocking orexin receptors to promote sleep onset and maintenance. Laboratories utilize high-quality… Read more
Daridorexant Hydrochloride is a dual orexin receptor antagonist used in the treatment of adult insomnia by blocking orexin receptors to promote sleep onset and maintenance. Laboratories utilize high-quality reference standards of Daridorexant Hydrochloride to support rigorous analytical testing and quality control protocols throughout the pharmaceutical development lifecycle. The category includes the active pharmaceutical ingredient, along with related substances such as synthesis impurities and process-related compounds, which are essential for comprehensive impurity profiling. Additionally, stable isotope labelled versions of the drug and its derivatives are available for use as internal standards in mass spectrometry-based assays. These materials facilitate precise method validation, ensuring accurate quantification and characterization of the drug substance and its associated impurities in complex matrices during stability studies and routine release testing.